Daily Commerce Martinique: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Daily Commerce Martinique.

Press releases published on November 9, 2026

Nov. 9, 2026

Castellum Announces $6.0 Million Share Repurchase Program

Indeterminate GlobeNewswire

Nov. 9, 2026

Oruka Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 9, 2026

AMC Global Media Inc. Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

Nov. 9, 2026

ParaZero Receives Additional 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Indeterminate GlobeNewswire

Nov. 9, 2026

Harrow Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 9, 2026

Globus Medical to Participate in Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 9, 2026

Oxbridge Reports Q3 2026 Results and Advances AI GridWorks’ Data Center Pipeline

Indeterminate GlobeNewswire

Nov. 9, 2026

MBX Biosciences Reports Third Quarter 2026 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire

Nov. 9, 2026

RAVE Restaurant Group, Inc. Reports First Quarter 2027 Results

Indeterminate GlobeNewswire

Nov. 9, 2026

ArriVent BioPharma Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 9, 2026

POLYRIZON ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN

Indeterminate GlobeNewswire

Nov. 9, 2026

Annexon Reports Third Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones

Indeterminate GlobeNewswire

Nov. 9, 2026

IRulya Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 9, 2026

SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.

Indeterminate GlobeNewswire

Nov. 9, 2026

Plug Reports Third Quarter Revenue of ~$201 Million, ~65 Percentage Point YoY Gross Margin Improvement, Record-Low Net Cash Usage with ~54% reduction sequentially

Indeterminate GlobeNewswire

Nov. 9, 2026

Black Diamond Therapeutics to Host Webcast Highlighting Updated Silevertinib Phase 2 Data and FDA Feedback Supporting a Clear Phase 3 Path to Potential Accelerated Approval in 1L EGFR-NCM NSCLC

Indeterminate GlobeNewswire

Nov. 9, 2026

Septerna Highlights Business Progress and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 9, 2026

Xenon Reports Q3 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 9, 2026

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

EquipmentShare Reports Third Quarter 2026 Results with Accelerated Organic Growth and Margin Expansion

Indeterminate GlobeNewswire